COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 1509: Articles 15081-15090  | Next

MALDI-ToF Protein Profiling as Potential Rapid Diagnostic Platform for COVID-19
Chivte, P., LaCasse, Z., Seethi, V. D. R., Bharti, P., Gaillard, E. R.
10.1101/2021.05.26.21257798 — Posted: 2021-05-30
Clinical Evaluation of In House Produced 3D Printed Nasopharyngeal Swabs for COVID-19 Testing
Grandjean Lapierre, S., Bedwani, S., Deblois, F., Fortin, A., Zamorano Cuervo, N., Zerouali, K., Caron, E., Morency Potvin, P., Gagnon, S., Nguissan, N., Arlotto, P., Hardy, I., Boutin, C.-A., Tremblay, C., Coutlee, F., de Guise, J., Grandvaux, N.
10.1101/2021.05.26.21257548 — Posted: 2021-05-30
Functional and quantitative evaluation of BNT162b2 SARS-CoV-2 vaccine-induced immunity
Kawasuji, H., Morinaga, Y., Tani, H., Saga, Y., Kaneda, M., Murai, Y., Ueno, A., Miyajima, Y., Fukui, Y., Nagaoka, K., Ono, C., Matsuura, Y., Niimi, H., Yamamoto, Y.
10.1101/2021.05.26.21257884 — Posted: 2021-05-30
Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: A cross-sectional survey
Villena-Tejada, M., Vera-Ferchau, I., Cardona-Rivero, A., Zamalloa-Cornejo, R., Quispe-Florez, M. M., Frisancho-Triveno, Z., Abarca-Melendez, R. C., Alvarez-Sucari, S. G., Mejia, C. R., Yanez, J. A.
10.1101/2021.05.26.21257890 — Posted: 2021-05-30
Out-of-Pocket Spending for COVID-19 Hospitalizations in 2020
Chua, K.-P., Conti, R. M., Becker, N. V.
10.1101/2021.05.26.21257879 — Posted: 2021-05-30
A rapid and simple protocol for concentration of SARS-CoV-2 from sewage
Wehrendt, D. P., Masso, M. G., Gonzales Machuca, A., Vargas, C. V., Barrios, M. E., Campos, J., Costamagna, D., Bruzzone, L., Cisterna, D. M., Iglesias, N. G., Mbayed, V. A., Baumeister, E., Centron, D., Quiroga, M. P., Erijman, L.
10.1101/2021.05.27.21257934 — Posted: 2021-05-30
Monitoring emergence of SARS-CoV-2 B.1.1.7 Variant through the Spanish National SARS-CoV-2 Wastewater Surveillance System (VATar COVID-19) from December 2020 to March 2021
Carcereny, A., Martinez-Velazquez, A., Bosch, A., Allende, A., Truchado, P., Cascales, J., Romalde, J. L., Lois, M., Polo, D., Sanchez, G., Perez-Cataluna, A., Diaz-Reolid, A., Anton, A., Gregori, J., Garcia-Cehic, D., QUER, J., Palau, M., Gonzalez Ruano, C., Pinto, R., Guix, S.
10.1101/2021.05.27.21257918 — Posted: 2021-05-30
Effectiveness of the Covid-19 vaccine in preventing infection in dental practitioners: results of a cross-sectional questionnaire based survey
Kumar, S., Saxena, S., Atri, M., Chamola, S. K.
10.1101/2021.05.28.21257967 — Posted: 2021-05-30
Modeling the impact of COVID-19 vaccination in Lebanon: A call to speed-up vaccine roll out
Mumtaz, G. R., El-Jardali, F., Jabbour, M., Harb, A., Abu-Raddad, L. J., Makhoul, M.
10.1101/2021.05.27.21257937 — Posted: 2021-05-30
CoMix: Changes in social contacts as measured by the contact survey during the 1 COVID-19 pandemic in England between March 2020 and March 2021
Gimma, A., Munday, J. D., Wong, K. L., Coletti, P., van Zandvoort, K., Prem, K., CMMID COVID 1-9 Working Group, , Klepac, P., Rubin, G. J., Funk, S., Edmunds, W. J., Jarvis, C. I.
10.1101/2021.05.28.21257973 — Posted: 2021-05-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).